Boston CE marks Express2 coronary stent:
This article was originally published in Clinica
Executive Summary
Boston Scientific has CE-marked for sale in Europe its Express2 coronary stent system. The product features the company's Bioslide hydrophilic coating, designed to reduce friction, its proprietary Crimp 360 technology, which secures the stent to the balloon, and a laser-bonded, flexible tip with a long, low profile that allows for easier tracking. The stent, which is also expected to provide a platform for Boston's Taxus drug-eluting stent programme, is scheduled for launch in Europe next week. A US launch is expected in September.